GR33861B - Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν. - Google Patents

Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν.

Info

Publication number
GR33861B
GR33861B GR670133861A GR670133861A GR33861B GR 33861 B GR33861 B GR 33861B GR 670133861 A GR670133861 A GR 670133861A GR 670133861 A GR670133861 A GR 670133861A GR 33861 B GR33861 B GR 33861B
Authority
GR
Greece
Prior art keywords
oral
parenteral
preparation
oxyteracycline
aquarium
Prior art date
Application number
GR670133861A
Other languages
Greek (el)
English (en)
Original Assignee
Koninklifke Nederlandsche Gist - En Spiritusfabriek N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklifke Nederlandsche Gist - En Spiritusfabriek N.V. filed Critical Koninklifke Nederlandsche Gist - En Spiritusfabriek N.V.
Publication of GR33861B publication Critical patent/GR33861B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR670133861A 1966-05-31 1967-05-22 Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν. GR33861B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (OSRAM) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
GR33861B true GR33861B (el) 1968-02-09

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
GR670133861A GR33861B (el) 1966-05-31 1967-05-22 Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν.

Country Status (22)

Country Link
US (1) US3557280A (OSRAM)
JP (1) JPS5010373B1 (OSRAM)
AT (1) AT272522B (OSRAM)
BE (1) BE699091A (OSRAM)
CH (1) CH490087A (OSRAM)
CS (1) CS151454B2 (OSRAM)
DE (1) DE1617576C3 (OSRAM)
DK (1) DK117587B (OSRAM)
ES (1) ES340956A1 (OSRAM)
FI (1) FI43622B (OSRAM)
FR (1) FR5953M (OSRAM)
GB (1) GB1131007A (OSRAM)
GR (1) GR33861B (OSRAM)
IL (1) IL28009A (OSRAM)
IT (1) IT1140250B (OSRAM)
LU (1) LU53788A1 (OSRAM)
MY (1) MY7100015A (OSRAM)
NL (1) NL6607516A (OSRAM)
NO (1) NO126298B (OSRAM)
SE (1) SE354417B (OSRAM)
SU (1) SU510986A3 (OSRAM)
YU (1) YU31326B (OSRAM)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (OSRAM) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
ATE523485T1 (de) 1999-09-14 2011-09-15 Tufts College Verfahren zur herstellung von substituierten tetracyclinen mit hilfe von auf übergangsmetalle basierten chemikalien
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
AU3105801A (en) * 2000-01-24 2001-07-31 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
ES2288945T3 (es) * 2000-03-31 2008-02-01 Trustees Of Tufts College Compuestos de tetraciclina 7 y 9-carbamato, urea, tiourea, tiocarbamato y heteroaril-amino sustituidos.
JP2003533504A (ja) 2000-05-15 2003-11-11 パラテック ファーマシューティカルズ インコーポレイテッド ７置換型縮合環テトラサイクリン化合物
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US6624168B2 (en) 2000-07-07 2003-09-23 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
EP2204361B1 (en) 2000-07-07 2011-09-28 Trustees Of Tufts College 13-substituted methacycline compounds
SI1301467T1 (sl) * 2000-07-07 2007-02-28 Tufts College 9-substituirane minociklinske spojine
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
KR101027625B1 (ko) 2000-07-07 2011-04-06 파라테크 파마슈티컬스, 인크. 7-치환 테트라사이클린 화합물
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP1955996A1 (en) 2001-03-13 2008-08-13 Paratek Pharmaceuticals, Inc. 7, 9-Substituted tetracycline compounds
EP1379255A2 (en) * 2001-03-14 2004-01-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
WO2002072031A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
ATE455092T1 (de) 2001-04-24 2010-01-15 Paratek Pharm Innc Substituierte tetracyclin-verbindungen zur behandlung von malaria
EP2311797A1 (en) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
CN101307017A (zh) 2002-03-08 2008-11-19 帕拉特克药品公司 氨基-甲基取代的四环素类化合物
IL164180A0 (en) 2002-03-21 2005-12-18 Paratek Pharm Innc Substituted tetracycline compounds
JP4416652B2 (ja) 2002-07-12 2010-02-17 パラテック ファーマシューティカルズ インコーポレイテッド ３、１０、および１２ａ置換されたテトラサイクリン化合物
CA2502464A1 (en) 2002-10-24 2004-05-06 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
CA2531728A1 (en) 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2292590A3 (en) 2003-07-09 2012-05-02 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP2332904A3 (en) 2004-01-15 2012-04-11 Paratek Pharmaceuticals, Inc. Derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
CA2585418A1 (en) * 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2284156A3 (en) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
WO2006084265A1 (en) 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. 11a, 12-DERIVATIVES OF TETRACYCLINE COMPOUNDS
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
CA2616224A1 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
EP1991236A2 (en) * 2006-01-24 2008-11-19 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
US20070244335A1 (en) * 2006-04-17 2007-10-18 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
US7871993B2 (en) * 2006-04-24 2011-01-18 Teva Pharmaceutical Industries Ltd. Tigecycline crystalline forms and processes for preparation thereof
AU2007249696A1 (en) * 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
WO2008079363A2 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
BRPI0720569B8 (pt) 2006-12-21 2021-05-25 Paratek Pharm Innc compostos de tetraciclina substituída e uso dos ditos compostos para o tratamento de uma infecção bacteriana, viral ou parasitária
US7935687B2 (en) * 2007-04-12 2011-05-03 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
EP2144870A2 (en) 2007-04-27 2010-01-20 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
EA201070233A1 (ru) 2007-07-06 2010-08-30 Паратек Фармасьютикалс, Инк. Способы синтеза замещённых соединений тетрациклина (варианты)
RU2010140682A (ru) 2008-03-05 2012-04-10 Пэрэтек Фамэсьютикэлс, Инк. (US) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
WO2009128913A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202216656A (zh) 2008-05-19 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
JP5553830B2 (ja) * 2008-07-21 2014-07-16 アルベマール・コーポレーシヨン 高含量イブプロフェンナトリウム顆粒、その調製、および非発泡性固体剤形を調製する際のその使用
CN102215681A (zh) * 2008-09-19 2011-10-12 帕拉特克药品公司 用于治疗类风湿性关节炎的四环素化合物和相关的治疗方法
EP2990051B1 (en) 2009-04-10 2016-10-26 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
HRP20191295T8 (hr) 2011-05-12 2020-02-07 Paratek Pharmaceuticals, Inc. Kristalne soli amida (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksilne kiseline i postupci uporabe istih
WO2018085216A1 (en) 2016-11-01 2018-05-11 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquire bacterial pneumonia (cabp)
AU2018303807B2 (en) 2017-07-21 2023-08-24 Almirall, Llc Treatment of non-inflammatory lesions

Also Published As

Publication number Publication date
CH490087A (de) 1970-05-15
SU510986A3 (ru) 1976-04-15
DE1617576C3 (de) 1980-12-11
SE354417B (OSRAM) 1973-03-12
IT1140250B (it) 1986-09-24
YU31326B (en) 1973-04-30
AT272522B (de) 1969-07-10
NO126298B (OSRAM) 1973-01-22
MY7100015A (en) 1971-12-31
LU53788A1 (OSRAM) 1967-07-31
BE699091A (OSRAM) 1967-11-27
ES340956A1 (es) 1968-06-16
DK117587B (da) 1970-05-11
IL28009A (en) 1970-08-19
JPS5010373B1 (OSRAM) 1975-04-21
GB1131007A (en) 1968-10-16
DE1617576B2 (de) 1980-04-10
NL6607516A (OSRAM) 1967-12-01
CS151454B2 (OSRAM) 1973-10-19
US3557280A (en) 1971-01-19
DE1617576A1 (de) 1972-04-27
FR5953M (OSRAM) 1968-04-16
FI43622B (OSRAM) 1971-02-01

Similar Documents

Publication Publication Date Title
GR33861B (el) Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν.
BE748970A (fr) Derives d'acides phenoxycarboxyliques
BG32717A3 (en) Method for obtaining of n- organo- n- phosphonomethylglicine- n- oxides
NO138615C (no) Anvendelse av et amin for fremstilling av vandige, stabile opploesninger av 1,2-benzisotiazolon
SE7611315L (sv) Prostansyraderivat och sett for framstellning derav
FI49723C (fi) Menetelmä antidepressiivisesti vaikuttavien -morfolino-p-amino-butyro fenonien sekä niiden suolojen valmistamiseksi.
CH546239A (fr) Procede de preparation de nouveaux derives de l'indole.
BG17955A3 (bg) Метод за получаване на 1- /2ч нитрилофенокси/ -2- хидрокси- 3- етилами- нопропан и неговите соли
ES326448A1 (es) Procedimiento de obtencion de una composicion terapeutica de accion mucolitica.
BE767527A (fr) Derives d'indole
BE763425A (fr) Procede de preparation de nouveaux derives de s-triazine et de leurs sels
BE808591A (fr) Derives d'acide amidomethane-phosphonique
ES376906A1 (es) Un metodo de obtencion de alfa-cetoglutarato de piridoxina y 5-hidroxitriptofano.
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
FR1536211A (fr) Procédé de préparation d'acides 2-alcoyl-3, 3-diphényl-acryliques et leurs sels
BE802539A (fr) Derives d'acides phenoxy-alicycliques-carboxyliques
BE777489A (fr) Membrane pour la dialyse par diffusion des acides et son procede de preparation
BE802345A (fr) Nouveau derive d'acide 1,4-dihydro-1-substitute-4-oxo-3-quinoleine-carboxylique
FR1511147A (fr) Nouveaux dérivés de la 11 h-dibenzotriazépine-1, 2, 5 et leurs sels, et procédéde préparation
SE383516B (sv) Forfarande for framstellning av pyridoxin och syraadditionssalter.
BE775257A (fr) Derives de l'acide diphenyl-propargylacetique et procede de preparatio
IT945964B (it) Sali basici di bismuto del polisac caride ottenuto per fermentazione di glucidi mediante xanthomanas cam pestris nrrl b 1459 e procedimento per prepararli
BE801332A (fr) Derives d'acides omega-aminoalcane-sulfoniques
IT994096B (it) Procedimento per la produzione di sali di aurammina e soluzioni di sali di aurammina
CH513167A (it) Procedimento di preparazione di sali de 4,4'-disolfossi-difenil-(2-piridil)-metano